Kalvista Pharmaceuticals Inc (KALV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KALV | LRMR | VERV | ||
| Company | Kalvista Pharmaceuticals Inc | Larimar Therapeutics Inc | Verve Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 9.02 | 6.12 | 4.55 | ||
| High | 9.21 | 6.29 | 4.69 | ||
| Low | 8.75 | 5.68 | 4.44 | ||
| Last | 9.08 | 6.10 | 4.60 | ||
| Change | +0.12 | +0.02 | +0.05 | ||
| % Change | +1.34% | +0.33% | +1.10% | ||
| Volume | 292,597 | 500,043 | 721,284 | ||
| 20-Day Average Volume | 407,867 | 755,962 | 1,619,148 | ||
| Previous Close | 8.96 | 6.08 | 4.55 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 10.62 | 7.73 | 5.71 | ||
| 20-Day Raw Stochastic | 8.78% | 9.42% | 6.96% | ||
| 20-Day Relative Strength | 36.39% | 39.69% | 38.90% | ||
| Weighted Alpha | -16.99 | -15.34 | -61.71 | ||
| Today's Opinion | 100% Sell | 88% Sell | 72% Sell | ||
| Previous Opinion | 100% Sell | 88% Sell | 72% Sell | ||
| Last Month's Opinion | 56% Sell | 40% Sell | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.04% since 11/14/24 | -19.62% since 11/14/24 | -14.41% since 11/14/24 | ||
| Low | 8.75 on 11/21/24 | 5.73 on 11/21/24 | 4.44 on 11/21/24 | ||
| High | 9.96 on 11/15/24 | 7.61 on 11/15/24 | 5.44 on 11/15/24 | ||
| 1-Month | |||||
| %Chg | -26.06% since 10/21/24 | -19.19% since 10/21/24 | -17.03% since 10/21/24 | ||
| Low | 8.75 on 11/21/24 | 5.73 on 11/21/24 | 4.44 on 11/21/24 | ||
| High | 12.85 on 11/04/24 | 9.50 on 11/11/24 | 6.81 on 11/06/24 | ||
| 3-Month | |||||
| %Chg | -27.58% since 08/21/24 | -25.25% since 08/21/24 | -10.06% since 08/21/24 | ||
| Low | 8.75 on 11/21/24 | 5.73 on 11/21/24 | 4.37 on 10/10/24 | ||
| High | 13.52 on 09/03/24 | 9.50 on 11/11/24 | 6.81 on 11/06/24 | ||
| 6-Month | |||||
| %Chg | -21.53% since 05/21/24 | -22.88% since 05/21/24 | -16.88% since 05/21/24 | ||
| Low | 8.75 on 11/21/24 | 5.73 on 11/21/24 | 4.30 on 08/14/24 | ||
| High | 15.50 on 07/24/24 | 11.20 on 07/16/24 | 7.96 on 07/16/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 387,206 | 387,947 | 385,221 | ||
| Shares Outstanding, K | 43,215 | 63,807 | 84,664 | ||
| Annual Sales | 0 | 0 | 11,760,000 | ||
| Annual Net Income | -126,640,000 | -36,950,000 | -200,070,000 | ||
| Last Quarter Sales | 0 | 0 | 6,870,000 | ||
| Last Quarter Net Income | -40,440,000 | -15,500,000 | -50,130,000 | ||
| 60-Month Beta | 0.92 | 0.95 | 1.75 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.87 on 09/05/24 | -0.24 on 10/30/24 | -0.59 on 11/05/24 | ||
| Latest Earnings Date | 12/05/24 | 11/12/24 | 11/05/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||